AR
AREV Life Sciences Global Corp
AREVF · OTC
$0.00 +0.00% (+$0.00)
Market Cap $22.6K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.46x
EV/EBITDA N/A
P/B N/A
Growth
0 /100
Declining Rev. growth 36.81%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 2,940.37%
Op. margin 2,827.74%
FCF margin 745.62%
Quality
61 /100
Average ROA 571.63%
Asset turnover 0.19x
ROIC 150.34%
Debt
50 /100
Moderate Int. coverage -236.17x
Net debt/EBITDA -0.02x
Current ratio 0.06x
Stability
16 /100
Unstable Rev. volatility 58.58%
EPS volatility 39.57%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre AREVF
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Michael C. Withrow
Employees
19,534
Headquarters
Coquitlam